Latest updates for Candida Auris

Fresh curated links around Candida auris are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Candida Auris
  • Pediatric recommendations for preventing and controlling Candida auris released
  • Macrophage Membrane-Derived Nanoparticles Shows Potential Against Candida Infections

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

planetayurveda.com /2 weeks ago

Candida Auris

Candida Auris – Indications, Preparation & Dosages Abstract Candida auris has emerged as a formidable multidrug-resistant fungal pathogen, challenging modern ... Read more The...

Read source
medicalxpress.com /3 weeks ago

Pediatric recommendations for preventing and controlling Candida auris released

The Society for Healthcare Epidemiology of America (SHEA) has released a new consensus statement providing pediatric-specific recommendations for the infection prevention and contr...

Read source
genengnews.com /6 days ago

Macrophage Membrane-Derived Nanoparticles Shows Potential Against Candida Infections

By coating biodegradable nanoparticles with macrophage membranes, scientists developed a targeted antifungal delivery platform that increased drug accumulation at infection sites a...

Read source
phys.org /2 weeks ago

Hidden for decades, hospital superbug built resistance in waves, peaking in the mid‑2000s

Decades-old hospital samples have helped University of East Anglia (UEA) researchers uncover how a deadly antibiotic-resistant "superbug" quietly tightened its grip across the glob...

Read source
fiercebiotech.com /4 weeks ago

F2G, Shionogi prep regulatory push after novel antifungal passes ph. 3 test

F2G and Shionogi have released phase 3 data for the oral antifungal drug olorofim, demonstrating its non-inferiority compared with an existing drug for invasive aspergillosis.

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Start creating posts

Sources covering Candida Auris

feeds.feedburner.com

Recent coverage from public sources
Public source

medicalxpress.com

Recent coverage from public sources
Public source

phys.org

Recent coverage from public sources
Public source

fiercebiotech.com

Recent coverage from public sources
Public source

planetayurveda.com

Recent coverage from public sources
Public source

Related searches

Antifungal Resistance Bloodstream Infection Candida auris Critical Care Diseases A-Z Drug Discovery Drug Resistant Fungus Elderly Health Emerging Fungal Infection Evolution Fungal Pathogens Healthcare Asso...

Recent searches

Artificial Intelligence Machine Learning Data Science Data Engineering Business Intelligence Web Development Software Development Software Testing Programming JavaScript DevOps Cyber Security Product Management Project Management Design UX UX Research Graphic Design Video Production Video Editing